377 related articles for article (PubMed ID: 29059230)
1. A structural explanation for the low effectiveness of the seasonal influenza H3N2 vaccine.
Wu NC; Zost SJ; Thompson AJ; Oyen D; Nycholat CM; McBride R; Paulson JC; Hensley SE; Wilson IA
PLoS Pathog; 2017 Oct; 13(10):e1006682. PubMed ID: 29059230
[TBL] [Abstract][Full Text] [Related]
2. Preventing an Antigenically Disruptive Mutation in Egg-Based H3N2 Seasonal Influenza Vaccines by Mutational Incompatibility.
Wu NC; Lv H; Thompson AJ; Wu DC; Ng WWS; Kadam RU; Lin CW; Nycholat CM; McBride R; Liang W; Paulson JC; Mok CKP; Wilson IA
Cell Host Microbe; 2019 Jun; 25(6):836-844.e5. PubMed ID: 31151913
[TBL] [Abstract][Full Text] [Related]
3. Contemporary H3N2 influenza viruses have a glycosylation site that alters binding of antibodies elicited by egg-adapted vaccine strains.
Zost SJ; Parkhouse K; Gumina ME; Kim K; Diaz Perez S; Wilson PC; Treanor JJ; Sant AJ; Cobey S; Hensley SE
Proc Natl Acad Sci U S A; 2017 Nov; 114(47):12578-12583. PubMed ID: 29109276
[TBL] [Abstract][Full Text] [Related]
4. Isolation of an Egg-Adapted Influenza A(H3N2) Virus without Amino Acid Substitutions at the Antigenic Sites of Its Hemagglutinin.
Kuwahara T; Takashita E; Fujisaki S; Shirakura M; Nakamura K; Kishida N; Takahashi H; Suzuki N; Kawaoka Y; Watanabe S; Odagiri T
Jpn J Infect Dis; 2018 May; 71(3):234-238. PubMed ID: 29709975
[TBL] [Abstract][Full Text] [Related]
5. Computationally Optimized Broadly Reactive Hemagglutinin Elicits Hemagglutination Inhibition Antibodies against a Panel of H3N2 Influenza Virus Cocirculating Variants.
Wong TM; Allen JD; Bebin-Blackwell AG; Carter DM; Alefantis T; DiNapoli J; Kleanthous H; Ross TM
J Virol; 2017 Dec; 91(24):. PubMed ID: 28978710
[TBL] [Abstract][Full Text] [Related]
6. Influenza H3N2 Vaccines: Recent Challenges.
Mostafa A; Pleschka S
Trends Microbiol; 2018 Feb; 26(2):87-89. PubMed ID: 29268980
[TBL] [Abstract][Full Text] [Related]
7. Effects of egg-adaptation on receptor-binding and antigenic properties of recent influenza A (H3N2) vaccine viruses.
Parker L; Wharton SA; Martin SR; Cross K; Lin Y; Liu Y; Feizi T; Daniels RS; McCauley JW
J Gen Virol; 2016 Jun; 97(6):1333-1344. PubMed ID: 26974849
[TBL] [Abstract][Full Text] [Related]
8. Elicitation of Protective Antibodies against 20 Years of Future H3N2 Cocirculating Influenza Virus Variants in Ferrets Preimmune to Historical H3N2 Influenza Viruses.
Allen JD; Jang H; DiNapoli J; Kleanthous H; Ross TM
J Virol; 2019 Feb; 93(3):. PubMed ID: 30429350
[TBL] [Abstract][Full Text] [Related]
9. A virus-like particle vaccination strategy expands its tolerance to H3N2 antigenic drift by enhancing neutralizing antibodies against hemagglutinin stalk.
Yang JR; Cheng CY; Chen CY; Lin CH; Kuo CY; Huang HY; Wu FT; Yang YC; Wu CY; Liu MT; Hsiao PW
Antiviral Res; 2017 Apr; 140():62-75. PubMed ID: 28093338
[TBL] [Abstract][Full Text] [Related]
10. Identification of Antibodies Targeting the H3N2 Hemagglutinin Receptor Binding Site following Vaccination of Humans.
Zost SJ; Lee J; Gumina ME; Parkhouse K; Henry C; Wu NC; Lee CD; Wilson IA; Wilson PC; Bloom JD; Hensley SE
Cell Rep; 2019 Dec; 29(13):4460-4470.e8. PubMed ID: 31875553
[TBL] [Abstract][Full Text] [Related]
11. In-depth phylogenetic analysis of the hemagglutinin gene of influenza A(H3N2) viruses circulating during the 2016-2017 season revealed egg-adaptive mutations of vaccine strains.
Galli C; Orsi A; Pariani E; Lai PL; Guarona G; Pellegrinelli L; Ebranati E; Icardi G; Panatto D
Expert Rev Vaccines; 2020 Jan; 19(1):115-122. PubMed ID: 31875483
[No Abstract] [Full Text] [Related]
12. Amino Acids in Hemagglutinin Antigenic Site B Determine Antigenic and Receptor Binding Differences between A(H3N2)v and Ancestral Seasonal H3N2 Influenza Viruses.
Wang X; Ilyushina NA; Lugovtsev VY; Bovin NV; Couzens LK; Gao J; Donnelly RP; Eichelberger MC; Wan H
J Virol; 2017 Jan; 91(2):. PubMed ID: 27807224
[TBL] [Abstract][Full Text] [Related]
13. Comparison of A(H3N2) Neutralizing Antibody Responses Elicited by 2018-2019 Season Quadrivalent Influenza Vaccines Derived from Eggs, Cells, and Recombinant Hemagglutinin.
Wang W; Alvarado-Facundo E; Vassell R; Collins L; Colombo RE; Ganesan A; Geaney C; Hrncir D; Lalani T; Markelz AE; Maves RC; McClenathan B; Mende K; Richard SA; Schofield C; Seshadri S; Spooner C; Utz GC; Warkentien TE; Levine M; Coles CL; Burgess TH; Eichelberger M; Weiss CD
Clin Infect Dis; 2021 Dec; 73(11):e4312-e4320. PubMed ID: 32898271
[TBL] [Abstract][Full Text] [Related]
14. Vaccination with 2014-15 Seasonal Inactivated Influenza Vaccine Elicits Cross-Reactive Anti-HA Antibodies with Strong ADCC Against Antigenically Drifted Circulating H3N2 Virus in Humans.
Zhong W; Gross FL; Holiday C; Jefferson SN; Bai Y; Liu F; Katz JM; Levine MZ
Viral Immunol; 2016 May; 29(4):259-62. PubMed ID: 26950058
[TBL] [Abstract][Full Text] [Related]
15. Immunodominance of Antigenic Site B in the Hemagglutinin of the Current H3N2 Influenza Virus in Humans and Mice.
Broecker F; Liu STH; Sun W; Krammer F; Simon V; Palese P
J Virol; 2018 Oct; 92(20):. PubMed ID: 30045991
[TBL] [Abstract][Full Text] [Related]
16. Antigenic assessment of the H3N2 component of the 2019-2020 Northern Hemisphere influenza vaccine.
Gouma S; Weirick M; Hensley SE
Nat Commun; 2020 May; 11(1):2445. PubMed ID: 32415074
[TBL] [Abstract][Full Text] [Related]
17. Addition of N-glycosylation sites on the globular head of the H5 hemagglutinin induces the escape of highly pathogenic avian influenza A H5N1 viruses from vaccine-induced immunity.
Hervé PL; Lorin V; Jouvion G; Da Costa B; Escriou N
Virology; 2015 Dec; 486():134-45. PubMed ID: 26433051
[TBL] [Abstract][Full Text] [Related]
18. H3N2 influenza viruses in humans: Viral mechanisms, evolution, and evaluation.
Allen JD; Ross TM
Hum Vaccin Immunother; 2018; 14(8):1840-1847. PubMed ID: 29641358
[TBL] [Abstract][Full Text] [Related]
19. Directed selection of influenza virus produces antigenic variants that match circulating human virus isolates and escape from vaccine-mediated immune protection.
DeDiego ML; Anderson CS; Yang H; Holden-Wiltse J; Fitzgerald T; Treanor JJ; Topham DJ
Immunology; 2016 Jun; 148(2):160-73. PubMed ID: 26854888
[TBL] [Abstract][Full Text] [Related]
20. Is seasonal vaccination a contributing factor to the selection of influenza epidemic variants?
Chong Y; Ikematsu H
Hum Vaccin Immunother; 2018 Mar; 14(3):518-522. PubMed ID: 28857677
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
